MFDS — authorised 17 August 2017
- Marketing authorisation holder: WYETH PHARMS INC
- Status: likely_approved
🇰🇷 Besponsa in South Korea
MFDS authorised Besponsa on 17 August 2017
Marketing authorisation
Besponsa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Besponsa approved in South Korea?
Yes. MFDS authorised it on 17 August 2017.
Who is the marketing authorisation holder for Besponsa in South Korea?
WYETH PHARMS INC holds the South Korean marketing authorisation.